U.S (New York) – Report Ocean has recently published a comprehensive research report titled “Asia-Pacific Nuclear Medicine Market” Research Report 2023-2031. This report delves deep into the market and offers valuable insights into (Key Market Trends, Emerging Technologies, Market Drivers and Challenges of the Industry, Regulatory Policies), company profiles of key players, and their strategies. With over 100+ market data tables, pie charts, graphs, and figures, this global market study is now available. The report provides a thorough evaluation of the market, (Encompassing Future Trends, Current Growth Factors, Expert Opinions, Factual Information), and industry-validated market data, with a forecast extending until 2031.
The Asia-Pacific nuclear medicine market was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028. The market is currently in its growth stage driven by increase in the number of cancer cases in the Asia-Pacific region and the surge awareness about nuclear medicine. Convenience of treatment with minimally invasive techniques attracts more patients toward the radiopharmaceuticals mode of treatment as compared to chemotherapy. The factors that drive the radiopharmaceuticals industry include increase in incidence of cardiac patients and adoption of clear imaging technique, with the help of diagnostic equipment such as PET and SPECT. The factors that hinder the growth of the market include supply shortages, logistical difficulties, and limited number of trained medical personnel.
Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1796
Radiopharmaceuticals are pharmaceutical formulations comprise radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance used in the treatment of cancer and cardiac & neurological disorders. Moreover, nuclear medicines of modality, SPECT and PET work as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices.
Applications such as lymphoma and bone metastasis use radiopharmaceuticals, also known as nuclear medicines. F-18, Tc-99, Ga-67, and I-123 are some of the nuclear medicines used in diagnostic procedures, while I-131, Ir192, Y-90, I-125, Lu-177, and Ra-223 are used in therapeutics procedure. More convenient therapeutic radiopharmaceuticals for oncology and cancer treatment replace the conventional chemotherapy methods to open up new avenues in the radiopharmaceuticals market.
The nuclear medicine market is categorized into type, modality, application, and end-user. On the basis of type, the market is segmented into diagnostics, therapeutics, and biochemistry research. The diagnostics segment led the market in 2020, and is anticipated to continue this trend during the forecast period, owing to the surge in prevalence of cancer that require early diagnosis for appropriate treatment could be provided in the Asia-Pacific region. Furthermore, rise in incidence of cardiac patients and clear imaging technique with the help of diagnostic equipment such as PET and SPECT is projected to help the diagnostics segment gain traction.
By modality, the Asia-Pacific nuclear medicine market is segregated into SPECT, PET, beta emitters, alpha emitters, brachytherapy, and others. The SPECT segment is expected to witness extensive market growth during the forecast period, owing to advantages of getting multiple 2-D and 3-D images, by performing SPECT imaging technique with the help of gamma camera aids in better access for the physicians to visualize the targeted area. Increase in the demand for the diagnosis of conditions such as cancer, cardiac, and neurology is expected to drive the growth of the industry during the forecast period.
By application, the Asia-Pacific nuclear medicine market is segregated into oncology, cardiology, thyroid, neurology and others. The oncology segment is expected to witness substantial market growth during the forecast period, owing to increase in cases of cancers and advancement of radio-therapeutics which has expedited the treatment process of cancerous tumors. However, thyroid segment is anticipated to gain highest CAGR, due to the growth in the number patient population in the coming years.
By end user, the Asia-Pacific nuclear medicine market is segregated into hospitals & diagnostics centers and research institutes. The hospitals & diagnostic centers segment is expected to witness significant market growth during the forecast period, owing to the surge in preference toward hospitals & diagnostic centers.
Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1796
By country, China is expected to register the highest revenue share during the forecast period pertaining to the higher targeted population base, surge in awareness regarding early diagnosis and therapeutics of cancer and cardiac ailments, and rise in disposable income. However, India is anticipated to gain fastest CAGR, owing to the surge in the patient population in the country. Competitive rivalry in the Asia-Pacific nuclear medicine market was observed at high level as major players have focused on the adoption of growth strategies such as product launches, mergers & acquisitions (M&As), and partnerships & collaborations to attain strong position in the competitive market.
According to data from the U.S. Bureau of Economic Analysis and the U.S. Census Bureau, the goods and services deficit increased by $1.9 billion from $68.7 billion in January 2023 to $70.5 billion in February. The increase in the goods and services deficit in February was due to a $2.7 billion increase in the goods deficit to $93.0 billion and a $0.8 billion increase in the services surplus to $22.4 billion. Compared to the same period in 2022, the goods and services deficit has dropped this year by $35.5 billion, or 20.3%. $49.5 billion or 10.8% more was exported. 2.2% or $14.0 billion more was spent on imports.
KEY BENEFITS FOR STAKEHOLDERS
– The study provides an in-depth analysis of the Asia-Pacific nuclear medicine market size along with the current trends and future estimations to elucidate the imminent investment pockets
– It offers market analysis from 2021 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
– A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
– The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the Asia-Pacific nuclear medicine market growth.
List of key players profiled in the report
– Bracco S.P.A. (Bracco Imaging S.P.A.)
– Bwx Technologies, Inc. (Nordion, Inc.)
– Cardinal Health, Inc.
– Danaher Corporation (GE Healthcare)
– FUJIFILM Toyama Chemical Co., Ltd. (FUJIFILM Holdings Corporation)
– Ion Beam Applications (Ion Beam Applications, SA)
– Lantheus Holdings, Inc. (Lantheus Medical Imaging, Inc.)
– Novartis AG (Advanced Accelerator Applications S.A.)
– Otsuka Holdings Co., Ltd. (ABX advanced biochemical compounds GmbH)
– Siemens Healthcare GmbH
KEY MARKET SEGMENTS
By Type
– Diagnostics
– Therapeutics
– Biochemistry Research
By Modality
– SPECT
– PET
– Beta Emitters
– Alpha Emitters
– Brachytherapy
– Others
By Application
– Oncology
– Cardiology
– Thyroid
– Neurology
– Others
By End User
– Hospitals & Diagnostics Centers
– Research Institutes
Request To Download Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=AMR1796
By Country
– Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Rest of Asia-Pacific
Why Choose Report Ocean Reports?
Uncovering business opportunities: Our market research reports are invaluable for analyzing potential markets and identifying new product opportunities. They provide insights into customer needs, preferences, and attitudes, as well as facilitate product and service comparisons.
Gaining a clear understanding of your customers: Market reports offer a comprehensive understanding of customers’ needs and desires, empowering your company’s marketing department to enhance products, reduce costs, and improve promotional strategies based on this valuable information.
Data-driven insights: Our market research encompasses a broad spectrum of activities, including market size determination, demand forecasting, competitor analysis, and price monitoring. All these aspects are quantified and measurable, providing you with tangible data-driven insights that enable informed decision-making.
Key Highlights:
Revenue and Sales Estimation: Our reports present historical revenue and sales volume data, which is further triangulated using top-down and bottom-up approaches to forecast the complete market size. Additionally, the report provides estimates for key regions, along with well-recognized types and end-use industries. Macroeconomic factors and regulatory policies are also considered for industry evolution and predictive analysis.
Five Forces Analysis: To enhance market understanding, we conduct a comprehensive five forces analysis that includes evaluating the bargaining power of buyers and suppliers, the threat of new entrants, the threat of substitutes, and the level of rivalry within the market.
Competition: We study leading players in the industry based on their company profile, product portfolio, capacity, product/service pricing, sales performance, and cost/profit analysis.
Demand & Supply and Effectiveness: Our reports provide insights into distribution channels, production, consumption, and, if applicable, import and export activities.
Request full Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1796
About US Report Ocean:
We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.
Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1888 212 3539 (US – TOLL FREE)
Email: sales@reportocean.com
Visit our news website: https://reportocean.com